Navigation Links
Cell Therapeutics, Inc. (CTI) Invest Northwest Presentation to be Webcast
Date:3/18/2008

SEATTLE, March 18 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTAX) management will present at the 7th Annual WBBA Invest Northwest Conference on Tuesday, March 18 at 9:00 AM Pacific Time (PT) in the Bay Auditorium of the Bell Harbor Conference Center.

The presentation will also be webcast live with slides, and available for replay after the presentation. The webcast can be accessed at http://www.celltherapeutics.com.

WBBA Invest Northwest Conference

CTI Presentation: Tuesday, March 18, 2008

9:00 AM PT/12:00 PM ET/5:00 PM CET

Bay Auditorium, Bell Harbor Conference Center

Audio webcast with slides at http://www.celltherapeutics.com

Media Contact:

Dan Eramian

T: 206.272.4343

C: 206.854.1200

F: 206.272.4434

E: media@ctiseattle.com

http://www.celltherapeutics.com/media.htm

Investors Contact:

Leah Grant

T: 206.282.7100

F: 206.272.4434

E: invest@ctiseattle.com

http://www.celltherapeutics.com/investors.htm


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities
2. Mercury Therapeutics, Inc: Lead Series of Indirect AMPK Activators Licensed to Makoto Life Sciences
3. Cell Therapeutics, Inc. (CTI) to Present at 7th Annual WBBA Invest Northwest Conference
4. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End Financial Results on March 13
5. Cell Therapeutics, Inc. to Hold Conference Call to Update on Recent Transactions and Upcoming Milestones
6. M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
7. Cell Therapeutics, Inc. (CTI) Announces Cancellation of Approximately $9.1 Million of Existing Notes due 2008
8. Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
9. Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008
10. Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO CEO & Investor Conference
11. Nile Therapeutics, Inc. to Present at Upcoming BIO CEO & Investor Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., Nov. 9 CEL-SCI Corpora...enneth S. Rosenthal, Professor of Immunology and M...ege of Medicine and Pharmacy, reported on work con...veland Clinic and CEL-SCI on CEL-SCI,s LEAPS vacci...GTCbio Vaccine: "All Things Considered" Conference...
(Date:11/8/2009)... VIEW, Calif. Nov. 5, 2009 Complete Genomics, a ...today announced publication of a report in the jou...encing platform, including analysis of sequence da...les cost for these three genomes sequenced on the ...rom $8,005 for 87x coverage to $1,726 for 45x cove...
(Date:11/6/2009)...s., Nov. 6 Myriant Technologies LL... and manufacturer of renewable bio-chemicals, Uhd...ogy provider Uhde GmbH, one of the world,s leading...ed an alliance for the engineering, procurement &a...nic Acid plants based on renewable feedstocks. Th...
(Date:11/6/2009)...lif., Nov. 6 Intarcia Therapeutics...CA 650 (DUROS® continuous delivery of exenati...t the Ninth Annual Diabetes Technology Meeting in ...m.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,, ...ITCA 650 Lowers Plasma Glucose, HbA1c and Reduces ...
Breaking Biology Technology:CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5
...healthcare giants, GE Healthcare and St. Jude Med...o develop a state-of-the-art cardiovascular ultras... disease. , ,Under terms of the agreement, the hea... integrated intracardiac echocardiography (ICE) im...s worldwide, enabling minimally invasive therapies...
...palities around the Midwest looking for new ways t...raditional approaches of bringing in developers to...thers are trying to entice businesses with tax inc...thin their municipalities. , ,This is a common pr...iving away tax incentives and adjusting building c...
...Wisconsin Angel Network , hoping to add another di...its new ePlan system to enable companies to use ri...r would-be investors. , ,The ePlan, which uses Med...d to help companies reach more investors with less...lane ticket, businesses seeking angel funding can ...
Other Biology Technology:GE, St. Jude to collaborate on visualization technology 2Electronic signs for municipalities: Las Vegas or lost revenues? 2Electronic signs for municipalities: Las Vegas or lost revenues? 3Electronic signs for municipalities: Las Vegas or lost revenues? 4Angel network introduces ePlan 2
(Date:11/9/2009)...duction method that begins by soaking corn kernels...s of ethanol and more usable co-products, giving e...about 20 percent. , "The conventional ethanol pr...stillers dried grains with soluble, it doesn,t hav...ois Agricultural Engineer Esha Khullar. "Whereas i...
(Date:11/9/2009)...ncer, the hopeful news is that pediatric survival ...e bad newstreatments that enable survival often ca...who have reached puberty currently have an opportu...g cancer treatment, they may have their semen froz...ever, do not produce sperm, although their testicu...
(Date:11/9/2009)...partment of Energy (DOE) has announced plans to fu...gham (UAB) School of Engineering on technologies t...ough the capture and permanent safe storage, or se...is in collaboration with Southern Company, the par...E through the 2009 American Recovery and Reinvestm...
Breaking Biology News(10 mins):Wet ethanol production process yields more ethanol and more co-products 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 3UAB, partners seek safe carbon dioxide storage for 'greener' power generation 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 3Overexpressed protein converts noninvasive breast cancer into invasive disease 56431 1Overexpressed protein converts noninvasive breast cancer into invasive disease 56431 2Overexpressed protein converts noninvasive breast cancer into invasive disease 56431 3Global Network for Neglected Tropical Diseases Partners with IDB PAHO to Control and Eliminate Neglected Tropical Diseases in Latin America Caribbea 56430 1Global Network for Neglected Tropical Diseases Partners with IDB PAHO to Control and Eliminate Neglected Tropical Diseases in Latin America Caribbea 56430 2Kidz Med Inc Receives Large Purchase Order Leading to Substantial Sales Increase at Beginning of Cough and Cold Season 56427 1Kidz Med Inc Receives Large Purchase Order Leading to Substantial Sales Increase at Beginning of Cough and Cold Season 56427 2Kidz Med Inc Receives Large Purchase Order Leading to Substantial Sales Increase at Beginning of Cough and Cold Season 56427 3
... 2008) -- On Nov. 8 and 9, Morgan Stanley Children...niversity Medical Center will host an "Innovations...att New York, which will feature lectures by inter...al research, genetic findings and stem cell therap... about congenital and primary immunodeficiencies; ...
...tudy led by investigators from Massachusetts Gener...look at how interactions between genes underlie a ...ory. Functional imaging studies reveal how a comb...ted with reduced activity of important brain struc...controls. The report has been released online in ...
...th expert Daniel Hayes, Ph.D., of the New York Cit... that a form of vitamin D could be one of our body... of radiation. Writing in the International Journ...ol, the active form of vitamin D, may protect us f...fe protective agent before or after a low-level nu...
Other Biology News:Innovations in Pediatric Medicine International Conference brings together pediatrics experts 2Interaction between gene variants may alter brain function in schizophrenia 2Could vitamin D save us from radiation? 2
Gold-plated 96-Well GeneAmp PCR System 9700 from Applied Biosystems
Rabbit Anti-ETR3 Antibody, Unconjugated from ABR-Affinity BioReagents
Mouse Anti-Human ABCG2 Monoclonal Antibody, Unconjugated, Clone 5D3 from R&D Systems
...fied Formulation: 50mM Tris-HCl, pH 7.5, 0.1mM EGT...% 2-mercaptoethanol and 50% glycerol. Properites: ... enzyme Purification: DEAE-Sephadex, ammonium sulf... Superdex 200, and Mono Q chromatography to >95%. ...
Biology Products: